Gennaro Cice
Overview
Explore the profile of Gennaro Cice including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
27
Citations
454
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Volterrani M, Cice G, Caminiti G, Vitale C, DIsa S, Filardi P, et al.
Int J Cardiol
. 2019 May;
288:114.
PMID: 31101222
No abstract available.
12.
Cice G
Eur Heart J Suppl
. 2019 Apr;
21(Suppl B):B38-B42.
PMID: 30948943
Heart failure and renal insufficiency often coexist in the same patient. Customarily, this condition is described as 'cardio-renal syndrome'. In this situation mortality increases significantly as the renal dysfunction worsen....
13.
Cice G
G Ital Cardiol (Rome)
. 2015 Dec;
16(12):675-80.
PMID: 26667944
Heart failure and renal failure often coexist in the same patient. This condition is commonly referred to as cardiorenal syndrome. When this occurs, patient survival worsens significantly with increasing degree...
14.
Savarese G, Rosano G, DAmore C, Musella F, Della Ratta G, Pellegrino A, et al.
Int J Cardiol
. 2013 Sep;
169(4):262-70.
PMID: 24063912
Background: Ranolazine (R), as add-on therapy in symptomatic patients with chronic stable coronary artery disease (CAD), has been tested in randomized clinical studies. Aim of the study was to assess...
15.
Volterrani M, Cice G, Caminiti G, Vitale C, DIsa S, Filardi P, et al.
Int J Cardiol
. 2011 Jul;
151(2):218-24.
PMID: 21764469
Aim: Patients with heart failure (HF) have reduced exercise capacity. The beneficial effect of beta-blocker on prognosis is not matched by an impact on exercise capacity and quality of life....
16.
Paterna S, Fasullo S, Parrinello G, Cannizzaro S, Basile I, Vitrano G, et al.
Am J Med Sci
. 2011 Jun;
342(1):27-37.
PMID: 21701268
Introduction: Hypertonic saline solution (HSS) and a moderate Na restriction plus high furosemide dose showed beneficial effects in compensated heart failure (HF), in short and long terms. The study was...
17.
Cice G, Di Benedetto A, DIsa S, DAndrea A, Marcelli D, Gatti E, et al.
J Am Coll Cardiol
. 2010 Nov;
56(21):1701-8.
PMID: 21070920
Objectives: the aim of this study was to determine whether telmisartan decreases all-cause and cardiovascular mortality and morbidity in hemodialysis patients with chronic heart failure (CHF) and impaired left ventricular...
18.
Cice G, Di Benedetto A, DAndrea A, DIsa S, De Gregorio P, Marcelli D, et al.
J Nephrol
. 2008 Oct;
21(5):704-12.
PMID: 18949725
Background: Several epidemiological studies have reported heart rate (HR) as a predictor of cardiovascular and noncardiovascular mortality in the general population. Aim of the present study was to investigate a...
19.
Esposito M, Cesare C, De Santo R, Cice G, Perna A, Violetti E, et al.
J Nephrol
. 2008 Jul;
21 Suppl 13:S92-6.
PMID: 18446739
Sleeping disorders are very common in patients with chronic kidney disease on dialysis (CKD5D) and are an emerging risk factor able to predict mortality. Parathyroid hormone (PTH) although considered a...
20.
De Santo R, Esposito M, Cesare C, Cice G, Perna A, Violetti E, et al.
J Ren Nutr
. 2007 Dec;
18(1):52-5.
PMID: 18089444
Objective: Although there has been contrasting evidence for a causative role of parathyroid hormone (PTH) in sleep disorders in patients on maintenance hemodialysis, a recent study disclosed the possibility that...